Reduction of Risk of Secondary Progressive Multiple Sclerosis Within Two Years of Treatment with Cladribine Tablets: An Analysis of the CLARITY Study

Journal article

Open access

Patrick Vermersch, Gavin Giovannoni, Per Soelberg Sørensen, Kottil Rammohan, Stuart Cook, Birgit Keller and Sanjeev Roy

Multiple sclerosis and related disorders, Vol.37, p.101602

2020-01

Files and links (1)

url

http://www.msard-journal.com/article/S2211034819305784/pdfView

Published (Version of record) Open

3 Record Views

Title: Reduction of Risk of Secondary Progressive Multiple Sclerosis Within Two Years of Treatment with Cladribine Tablets: An Analysis of the CLARITY Study
Creators: Patrick Vermersch - University of Lille
Gavin Giovannoni - Queen Mary University of London
Per Soelberg Sørensen - University of Copenhagen
Kottil Rammohan - University of Miami
Stuart Cook - Rutgers, The State University of New Jersey, New Jersey Medical School, Newark, United States
Birgit Keller - Merck KGaA, Darmstadt, Germany
Sanjeev Roy - Merck, Aubonne, Switzerland
Publication Details: Multiple sclerosis and related disorders, Vol.37, p.101602
Publisher: Elsevier B.V
Academic Unit: Miller School of Medicine; UMMG Department of Neurology; UMMG Dept of Neurology - Multiple Sclerosis Div
Language: English
Resource Type: Journal article
Record Identifier: 991031757322802976